BioLineRx (BLRX) EBT (2011 - 2025)
BioLineRx's (BLRX) quarterly EBT came in at -$2.2 million in Q4 2025, up 29.84% year-on-year from -$1.7 million in Q4 2024, and down 128.86% quarter-over-quarter from -$977000.0 in Q3 2025.
BioLineRx (BLRX) EBT (2011 - 2025) Analysis & Trends
BioLineRx's EBT history runs 14 years deep, the most recent figure standing at -$2.2 million for Q4 2025.
- On a quarterly basis, EBT rose 29.84% year-over-year to -$2.2 million in Q4 2025; TTM through Dec 2025 was -$2.0 million, a 78.03% increase from a year earlier, with the FY2025 full-year figure at -$2.0 million, up 78.03% from the prior year.
- EBT fell to -$2.2 million in Q4 2025 per BLRX's latest filing, from -$977000.0 in the prior quarter.
- Across five years, EBT topped out at $5.1 million in Q1 2025 and bottomed at -$23.1 million in Q4 2023.
- The 5-year median for EBT is -$6.0 million (2021), against an average of -$5.8 million.
- Biggest YoY gain for EBT was 836.64% in 2025; the steepest drop was 533.92% in 2025.
- Year by year, EBT stood at -$8.1 million in 2021, then sank by 30.21% to -$10.6 million in 2022, then slumped by 117.97% to -$23.1 million in 2023, then surged by 86.18% to -$3.2 million in 2024, then climbed by 29.84% to -$2.2 million in 2025.
- Per Business Quant, the three latest BLRX EBT figures stand at -$2.2 million (Q4 2025), -$977000.0 (Q3 2025), and -$3.9 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | -2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.24 Mn |
| Sep 30, 2025 | -977,000.00 |
| Jun 30, 2025 | -3.94 Mn |
| Mar 31, 2025 | 5.13 Mn |
| Dec 31, 2024 | -3.19 Mn |
| Sep 30, 2024 | -6.25 Mn |
| Jun 30, 2024 | 908,000.00 |
| Mar 31, 2024 | -696,000.00 |
| Dec 31, 2023 | -23.06 Mn |
| Sep 30, 2023 | -11.21 Mn |
| Jun 30, 2023 | -8.14 Mn |
| Mar 31, 2023 | -7.39 Mn |
| Dec 31, 2022 | -10.58 Mn |
| Sep 30, 2022 | -6.70 Mn |
| Jun 30, 2022 | -7.14 Mn |
| Mar 31, 2022 | -5.83 Mn |
| Dec 31, 2021 | -8.12 Mn |
| Sep 30, 2021 | -5.90 Mn |
| Jun 30, 2021 | -6.14 Mn |
| Mar 31, 2021 | -5.03 Mn |